Danone
Danone is a $27-billion global food giant that sells you "health", and has spent decades in court, in controversy, and under activist pressure over exactly that claim.
Danone S.A. is a French multinational headquartered in Paris, operating in four core categories: essential dairy and plant-based products, waters, early life nutrition (infant formula), and medical nutrition. Founded in Barcelona in 1919 by Isaac Carasso, who named the company after his son Daniel (“Danon” in Catalan), it is today one of the largest food and beverage companies on the planet by revenue, with products sold in over 120 countries.
The company is publicly traded on Euronext Paris (ticker: BN) and is a component of the CAC 40 index. Despite its size, Danone markets itself relentlessly around health, sustainability, and its unique “dual project”, the idea that economic performance and social progress are inseparable. Critics, regulators, and short-sellers have spent years stress-testing that narrative.
People search for Danone because the gap between its health-brand positioning and its legal, ethical, and financial track record is genuinely wide. From a $21 million FTC settlement over probiotic claims to its entanglement in the infant-formula industry, to activist investors forcing out its long-serving CEO in 2021, the brand keeps generating questions it would rather not answer.
In the US, the brand trades under the name Dannon, a legacy quirk of its American history that confuses consumers constantly and drives a huge slice of the search traffic this page addresses. Whether you’re a shareholder watching the stock, a parent buying formula, or a shopper scanning a yogurt label, Danone’s sprawling portfolio touches your life more than you probably realize.